Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
Another drugmaker, Viiv Healthcare, also left out most of Latin America when it allowed generics of its HIV prevention shot ...
It’s been called the closest the world has ever come to a vaccine against AIDS. The twice-yearly shot was 100% effective in ...